RQ Bio welcomes positive CHMP opinion on Kavigale for prevention of COVID-19 in immunocompromised individuals Kavigale ...

欧盟人用医药产品委员会 (CHMP)对Celltrion的三种候选生物仿制药——Eydenzelt® (aflibercept)、Stoboclo®和Osenvelt® (denosumab)以及Avtozma® (tocilizumab)给出积极意见 ...

Prurigo nodularis is a serious skin condition characterized by several debilitating symptoms, including chronic itch, skin nodules covering large body areas, and poor sleep quality. 5-7,10 The ...

阿斯利康和第一三共近期宣布自愿撤回其在欧盟申请的抗体-药物偶联物——德曲妥珠单抗（Dato-DXd）用于局部晚期或转移性非鳞状非小细胞肺癌（NSCLC）的上市许可申请。这一决定是基于来自欧洲药品管理局（EMA）人用药品委员会（CHMP）的反馈而做出的。这两家公司原本寄希望于通过上市许可申请获批，促使这一新药治疗更多的非小细胞肺癌患者。 数据显示，早在3月份，依据两家公司在TROPION-Lung0 ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that nemolizumab be used subcutaneously to treat atopic dermatitis patients aged 12 years and older, and in adults with ...

If the EMA follows the CHMP’s advice, Zynquista will become the second SGLT-acting drug to be approved for use alongside insulin in type 1 diabetes after AstraZeneca’s SGLT2 inhibitor Forxiga ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and ...

The CHMP has recommended nemolizumab’s approval for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic ...

RQ Bio welcomes positive CHMP opinion on Kavigale for prevention of COVID-19 in immunocompromised individuals Kavigale (sipavibart; AZD3152) is a monoclonal antibody discovered by RQ Bio and ...